- Home
- BZ vs NUVL Comparison
BZ vs NUVL Comparison
Compare BZ & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZ
- NUVL
- Stock Information
- Founded
- BZ 2013
- NUVL 2017
- Country
- BZ China
- NUVL United States
- Employees
- BZ N/A
- NUVL N/A
- Industry
- BZ Computer Software: Programming Data Processing
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- BZ Technology
- NUVL Health Care
- Exchange
- BZ Nasdaq
- NUVL Nasdaq
- Market Cap
- BZ 6.9B
- NUVL 5.6B
- IPO Year
- BZ 2021
- NUVL 2021
- Fundamental
- Price
- BZ $17.65
- NUVL $77.18
- Analyst Decision
- BZ Buy
- NUVL Strong Buy
- Analyst Count
- BZ 3
- NUVL 8
- Target Price
- BZ $17.67
- NUVL $115.50
- AVG Volume (30 Days)
- BZ 2.9M
- NUVL 544.2K
- Earning Date
- BZ 05-22-2025
- NUVL 05-08-2025
- Dividend Yield
- BZ N/A
- NUVL N/A
- EPS Growth
- BZ 41.16
- NUVL N/A
- EPS
- BZ 0.56
- NUVL N/A
- Revenue
- BZ $1,043,919,383.00
- NUVL N/A
- Revenue This Year
- BZ $15.61
- NUVL N/A
- Revenue Next Year
- BZ $13.24
- NUVL N/A
- P/E Ratio
- BZ $30.04
- NUVL N/A
- Revenue Growth
- BZ 18.77
- NUVL N/A
- 52 Week Low
- BZ $10.57
- NUVL $55.54
- 52 Week High
- BZ $21.99
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- BZ 55.99
- NUVL 59.25
- Support Level
- BZ $17.12
- NUVL $70.25
- Resistance Level
- BZ $17.91
- NUVL $75.97
- Average True Range (ATR)
- BZ 0.56
- NUVL 3.12
- MACD
- BZ -0.05
- NUVL 0.33
- Stochastic Oscillator
- BZ 56.70
- NUVL 96.39
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on average number of monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.